PERSPECTA

News from every angle

← Back to headlines

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion  Reuters

23 Feb, 11:08 — 23 Feb, 11:08
PostShare

Sources

Showing 1 of 1 sources
ReutersVery High44d ago

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - Reuters

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion  Reuters

Read full article →

Related Stories

Brian Poe calls for ‘people’s hearing’ on oil crisis, energy reforms

just now

Manila Water Prepares for Summer Heat and High Demand

just now

CHEd allows HEIs to shift to online classes amid oil crisis

just now

Philippine Lottery Draws Yield No Jackpot Winners on April 8

just now